RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

By admin 2 days ago7 views

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

admin

Website

Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow

Leading gold analysis firm Metals Focus published its annual flagship Gold Focus report on Thursday ...

admin

05Jun2025

Prismo Metals Appoints Gordon Aldcorn as President

(TheNewswire) Vancouver, British Columbia TheNewswire – June 5th, 2025 Prismo Metals Inc. (the ‘ Company ...

admin

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

5 Biggest Blockchain ETFs in 2025

Popular News

Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

5 Biggest Blockchain ETFs in 2025

You may also like

Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow

Prismo Metals Appoints Gordon Aldcorn as President

Popular News